Glutamate is the primary excitatory neurotransmitter in the human brain. Excitatory synaptic activity conveyed by glutamate is mediated by three pharmacologically defined subtypes of ionotropic glutamate receptors: N-methyl-D-aspartate (NMDA), D, L-␣ -amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) and kainate. The NMDA receptor comprises two subunits that are coded by genes designated NR1 and NR2A-D. Non-NMDA glutamate receptor subunits comprise GluR1-4, which are AMPA-preferring, and GluR5-7, KA1 and KA2, which are kainate preferring (Hollmann and Heinemann 1994) .
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Pharmacological and biochemical data have suggested deficiency in glutamatergic transmission in schizo-phrenia. Low concentrations of glutamate have been reported in cerebrospinal fluid samples from schizophrenic patients (Kim et al. 1980) ; however, the most convincing evidence of the glutamate hypofunction hypothesis of schizophrenia is based on the fact that phencyclidine (PCP), a psychotomimetic drug that blocks the NMDA receptor, produces a syndrome that appears similar to schizophrenia (Javitt and Zukin 1991) . PCP binds to a site in the ion channel which is gated by the NMDA-type glutamate receptor (Reynolds and Miller 1990) . PCP and other NMDA channel blockers, such as MK-801 and ketamine, act as a non-competitive antagonists of glutamate-mediated ion conductances. Hence, PCP psychosis is thought to be the result of reduced NMDA receptor function.
Although it is usually the NMDA receptor that is implicated in schizophrenia, disturbances of any of the glutamate receptors could result in a condition that produces the appearance of an abnormally functioning NMDA receptor. For example, NMDA receptors are blocked by magnesium at physiological concentrations, and AMPA receptor-mediated depolarization of the membrane extrudes magnesium from the NMDA receptor complex (Reynolds and Miller 1990) . Therefore, a pathological change in the function of non-NMDA receptors may affect the NMDA receptor.
Given the possibility of glutamate receptor dysfunction in schizophrenia, the expression of ionotropic glutamate receptors has been studied in post-mortem brain of schizophrenia patients and abnormalities in glutamate receptors have been reported in many brain areas (reviewed by Meador-Woodruff and Healy 2000; see also Deakin and Simpson 1997) . Some of these reports have not been replicated and have been done primarily in membrane preparations. These studies illustrate that the occurrence and nature of glutamate receptor abnormalities in schizophrenia can differ between brain regions.
The anterior cingulate cortex (ACC; Brodmann's area 24) is localized within a gyrus on the media surface of each hemisphere, bordering on the corpus callosum. It receives projections from the amygdala (Vogt and Pandya 1987) , thalamus (Vogt et al. 1979 ) and hippocampus (Vogt et al. 1979; Tamminga et al. 2000) , possibly excitatory in nature. Abnormalities in glutamatergic neurotransmission have been reported in the ACC in schizophrenia. Recent studies using post-mortem human ACC indicate a dramatic increase in vertical glutamatergic axons in the superficial layers of ACC in schizophrenia (Benes 2000) and imaging studies suggest impaired activation of ACC in patients with schizophrenia during performance tasks, which could be attributed to a reduced efferent glutamatergic signal from the hippocampus to ACC (see Tamminga et al. 2000 for a review). In addition, there is a growing evidence indicating abnormalities in other neurotransmitter systems in the ACC in schizophrenia including dopamine, GABA, and serotonin, that could contribute to an abnormal excitatory activity in this brain area (Benes 2000; Zavitsanou and Huang 2002) .
Since a disturbed balance in the excitatory neurotransmission is suggested to occur in the ACC in schizophrenia, the present study has focused on the analysis of the binding of [ Cases were excluded where there was a significant history of drug or alcohol abuse (that would meet diagnostic criteria according to DSM IIIR or IV), neurologic disorder or medical illness that may influence agonal state, any abnormality on neuropathological examination, or head injury or where the post-mortem interval exceeded 48 h. Ten cases without any documented history of psychiatric disorders and ten cases with a diagnosis of schizophrenia, matched for age, gender and postmortem interval, were used in this study.
MATERIALS AND METHODS

Postmortem Brain Tissue
The diagnosis of schizophrenia was confirmed after review of all available medical records. From this review a treatment summary was constructed. Two instruments designed for use with medical records were then used on the information obtained to confirm the diagnosis: The Item Group Checklist of the Schedules for Clinical Assessment in Neuropsychiatry (SCAN, Jablensky et al. 1993 ) and the Diagnostic Instrument for Brain Studies (DIBS, Keks et al. 1999) . Eight of the cases (cases 1-8, Table 1 ) were diagnosed according to DSM III-R using the SCAN. Two cases (9,10, Table 1) were diagnosed according to DSM-IV using the DIBS. Both instruments have proven reliability. The mean age of onset of schizophrenia was 24.9 Ϯ 5.9 years and the mean duration of the illness was 17.2 Ϯ 11.9 years. The illness subtype was undifferentiated (n ϭ 4), paranoid (n ϭ 4) or residual (n ϭ 2). All subjects with schizophrenia had been treated with various forms of anti-psychotic medication over a number of years before death and, based on toxicology reports, eight out of ten cases were medicated at the time of death (Table 1) .
The control cases were confirmed through extensive contact with area health hospitals, and the subject's family physician. Medical records were reviewed to exclude any history of major psychiatric disorders and, if necessary to exclude possible psychopathology, discussion took place with the family physician. Brains were sliced in the coronal plane at approximately 1 cm thickness. Tissue blocks were taken from the left side of ACC and were immediately frozen at Ϫ 80 Њ C until the assays. All assays described below were carried out blind of diagnosis.
Autoradiography
Sections of 16 m thickness were cut at Ϫ 18 Њ C using a cryostat (Jung CM300, Leica), mounted onto gelatincoated slides and stored at Ϫ 20 Њ C until they were used. Sections from both schizophrenia and control cases were randomly selected from levels equivalent to plates 5 and 6 of the Atlas of the Human Brain (Mai et al. 1997) . Tissues from normal and schizophrenic cases were sectioned alternately to avoid a sequencing bias that might potentially be incurred during cutting and storage of the sections. All control and schizophrenic tissue sections were processed simultaneously to minimize experimental variance. For each ligand one experimental run was conducted and all subjects were included.
[ 3 H]AMPA binding was performed as previously described (Zavitsanou et al. 1996) . Briefly, all sections underwent a pre-wash for 30 min at 4 Њ C in 50 mM TrisHCl buffer (pH 7.2) containing 2.5 mM CaCl 2 . Four sections per case were then incubated for 60 min at 4 Њ C in 50 mM Tris-HCl buffer (pH 7.2) containing 63nM [ 3 H]AMPA (specific activity 48.7 Ci/mmol, NEN, USA) in the presence of 2.5 mM CaCl 2 and 100 mM potassium thiocyanate (KSCN). Two additional sections per case were incubated with [ 3 H]AMPA in the presence of 1 mM glutamic acid to determine non-specific binding. After the incubation, the sections were rinsed three times in cold 50 mM Tris-HCl buffer containing 2.5 mM CaCl 2 for 60 s and dried with warm air.
[ 3 H]Kainate binding was performed as previously described (Zavitsanou et al. 1996) with minor modifications. Briefly, all sections underwent a pre-wash for 30 min at 4 Њ C in 0.31M Tris-citrate buffer (pH 7.3). Four sections per case were then incubated for 2 h at 4 Њ C in 0.31M Tris-citrate buffer (pH 7.3) containing 42nM [ 3 H]kainate (specific activity 58 Ci/mmol, NEN, USA). Two additional sections per case were incubated with [ 3 H]kainate in the presence of 1 mM glutamic acid to determine non-specific binding. After the incubation, the sections were rinsed twice for 1 min each time, in cold 0.31M Tris-citrate buffer with a final dip in ice-cold dH 2 O and dried with warm air.
[ 3 H]MK-801 binding was performed according to the method by Ekonomou and Angelatou (1999) . Briefly, on the day of the experiment all slides were thawed at room temperature and air-dried. Two sections per case were then incubated in 30 mM N-(2-Hydroxyethyl) pip- Microscales from Amersham were used as standards. Autoradiographs were developed at room temperature in Ilford (Phenisol) X-ray developer (4 min) and exposed to cold tap water (15 sec), Ilford (Hypam) X-ray fixer (4 min), cold tap water (10 min) and room temperature air to dry.
Quantitative Analysis of Autoradiographic Images
Quantification analysis of the resulting autoradiographic images was performed by using a computer assisted image analysis system (Multi Analyst, BIO-RAD, USA), connected to a GS-690 Imaging Densitometre. Optical density measurements were taken from both the proisocortical and isocortical part of Brodmann's area 24 (Zilles 1990 ). For the confirmation of anatomical structures, sections were stained with cresyl violet (Paxinos et al. 2000) after the development of the autoradiographs. Section images on the film were then superimposed on the stained sections and observed under an Olympus BX-50 microscope to determine the distribution of each ligand among the cortical layers.
Since the three ligands displayed different distribution among cortical layers measurements were averaged from different representative compartments of the 
RESULTS
Autoradiographs of all three binding sites in representative schizophrenia and control cases are shown in Figure The principal laminar patterns of each binding site were similar in both schizophrenia and control groups. AMPA receptor densities were higher in cortical layer II whereas NMDA receptor densities were higher in cortical layers II-III in the ACC of both control and schizophrenia groups. In contrast, kainate receptors displayed the highest density in cortical layer V. These results are in agreement with previous autoradiographic studies indicating high densities of AMPA and NMDA receptors in superficial layers and high densities of kainate receptors in deep layers of neocortex (Monaghan et al. 1984; Cotman 1985, 1982) .
A potential confounding factor in all studies in schizophrenia is the possible effects of antipsychotic medication. Based on toxicology reports eight out of ten schizophrenia patients were under medication at the time of death. Although three schizophrenia patients were free of neuroleptics at death, their medication history indicates that they were receiving antipsychotics during life. Recent animal studies indicate reduction of [ demonstrates an upregulation of native AMPA receptors containing the pharmacologically and functionally important AMPA binding site. In addition, methodological differences may account for this discrepancy. In our study statistically significant upregulation of AMPA receptors was observed in layer II only, whereas Breese et al. (1995) used membrane preparations from the entire cingulate cortical region.
The results of the present study are in agreement with animal studies modeling NMDA receptor hypofunction in rats, after administration of PCP. Recent studies reported heightened depolarization of cortical pyramidal neurons after application of exogenous NMDA in PCP-treated rats relative to controls (Arvanov and Wang 1999) . One interpretation of these data is that prolonged reduction in glutamatergic transmission in the prefrontal cortex, caused by PCP, is associated with an upregulation of NMDA receptors, and thus the response to exogenous NMDA application is amplified. In agreement with this hypothesis increased expression of GluR1 (a subunit of the AMPA receptor) and NMDAR1 have been shown in rat prefrontal cortex after repeated exposures to PCP (see Jentsch and Roth 1999 and references therein) .
One explanation of the present findings could be based on the suggestion that the ACC in schizophrenia receives an abnormally dense glutamatergic innervation, that possibly originates in the basolateral nucleus of the amygdala (Benes 2000) . Increased numbers of glutamatergic afferent axons would result in increased glutamate uptake and therefore reduced synaptic levels of glutamate, sufficiently to induce a compensatory increase in postsynaptic AMPA and NMDA receptors. In agreement with this notion, reduced glutamate concentrations in cerebrospinal fluid in schizophrenia have been reported (Kim et al. 1980 ). However to prove such a hypothesis it is necessary to asses the function of presynaptic glutamatergic system in the ACC in schizophrenia. [ 3 H]-D-aspartate binds with high affinity to the glutamate uptake site, and it is thus a marker for the integrity of pre-synaptic glutamate terminals. Importantly, increased [ 3 H]-D-aspartate binding has been observed in membrane preparations of the ACC in schizophrenia although in borderline significance, which indicates that problems may be confined to a few cortical laminae (Simpson et al. 1998) .
Another possible explanation of the present finding could be based on the suggestion that a primary abnormality in the hippocampus in schizophrenia is associated with a reduced efferent hippocampal glutamate signal to ACC (see Tamminga et al. 2000 for a review). It is therefore reasonable to hypothesize that a reduced efferent glutamatergic signal from the hippocampus would result in compensatory upregulation of AMPA and NMDA receptors in the ACC.
In summary, the increases in NMDA and AMPA receptor densities in the superficial layers of ACC in schizophrenia suggest a dysfunction of glutamatergic neurotransmission that could theoretically alter intrinsic circuits and result in abnormal information processing. The findings add to a growing body of literature that supports abnormalities in the excitatory neurotransmission in the ACC in schizophrenia.
